Björklund, A. & Dunnett, S. B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194–202 (2007).
Hegarty, S. V., Sullivan, A. M. & O’Keeffe, G. W. Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development. Dev. Biol. 379, 123–138 (2013).
Maiti, P., Manna, J., Dunbar, G. L., Maiti, P. & Dunbar, G. L. Current understanding of the molecular mechanisms in Parkinson’s disease: targets for potential treatments. Transl. Neurodegener. 6, 1–35 (2017).
Kalia, L. V. & Lang, A. E. Parkinson’s disease. Lancet 386, 896–912 (2015).
Morales, M. & Margolis, E. B. Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat. Rev. Neurosci. 18, 73–85 (2017).
Meyer-Lindenberg, A. et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat. Neurosci. 5, 267–271 (2002).
Milton, A. L. & Everitt, B. J. The persistence of maladaptive memory: addiction, drug memories and anti-relapse treatments. Neurosci. Biobehav. Rev. 36, 1119–1139 (2012).
Fu, Y. H. et al. A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse. Brain Struct. Funct. 217, 591–612 (2012).
Damier, P., Hirsch, E. C., Agid, Y. & Graybiel, A. M. The substantia nigra of the human brain: I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry. Brain 122, 1421–1436 (1999).
Grimm, J., Mueller, A., Hefti, F. & Rosenthal, A. Molecular basis for catecholaminergic neuron diversity. Proc. Natl Acad. Sci. USA 101, 13891–13896 (2004).
Greene, J. G., Dingledine, R. & Greenamyre, J. T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol. Dis. 18, 19–31 (2005).
Chung, C. Y. et al. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum. Mol. Genet. 14, 1709–1725 (2005).
Brochier, C. et al. Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models. Physiol. Genomics 33, 170–179 (2008).
Brichta, L. et al. Identification of neurodegenerative factors using translatome–regulatory network analysis. Nat. Neurosci. 18, 1325–1333 (2015).
Tiklová, K. et al. Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development. Nat. Commun. 10, 1–12 (2019).
Hook, P. W. et al. Single-cell RNA-Seq of mouse dopaminergic neurons informs candidate gene selection for sporadic parkinson disease. Am. J. Hum. Genet. 102, 427–446 (2018).
Saunders, A. et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell 174, 1015–1030.e16 (2018).
La Manno, G. et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell 167, 566–580.e19 (2016).
Poulin, J.-F., Gaertner, Z., Moreno-Ramos, O. A. & Awatramani, R. Classification of midbrain dopamine neurons using single-cell gene expression profiling approaches. Trends Neurosci. 43, 155–169 (2020).
Poulin, J. F. et al. Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. Cell Rep. 9, 930–943 (2014).
Kramer, D. J., Risso, D., Kosillo, P., Ngai, J. & Bateup, H. S. Combinatorial expression of Grp and Neurod6 defines dopamine neuron populations with distinct projection patterns and disease vulnerability. eNeuro 5, ENEURO.0152-18.2018 (2018).
Farassat, N. et al. In vivo functional diversity of midbrain dopamine neurons within identified axonal projections. Elife 8, e48408 (2019).
Beier, K. T. et al. Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping. Cell 162, 622–634 (2015).
Beier, K. T. et al. Topological organization of ventral tegmental area connectivity revealed by viral-genetic dissection of input-output relations. Cell Rep. 26, 159–167 (2019).
Lammel, S., Ion, D. I., Roeper, J. & Malenka, R. C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70, 855–862 (2011).
Lammel, S. et al. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57, 760–773 (2008).
de Jong, J. W. et al. A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system. Neuron 101, 133–151.e7 (2019).
Tang, W., Kochubey, O., Kintscher, M. & Schneggenburger, R. A VTA to basal amygdala dopamine projection contributes to signal salient somatosensory events during fear learning. J. Neurosci. 40, 3969–3980 (2020).
Lerner, T. N. et al. Intact-brain analyses reveal distinct information carried by SNc dopamine subcircuits. Cell 162, 635–647 (2015).
Bimpisidis, Z. et al. The NeuroD6 subtype of VTA neurons contributes to psychostimulant sensitization and behavioral reinforcement. eNeuro 6, ENEURO.0066-19.2019 (2019).
Viereckel, T. et al. Midbrain gene screening identifies a new mesoaccumbal glutamatergic pathway and a marker for dopamine cells neuroprotected in Parkinson’s disease. Sci. Rep. 6, 35203 (2016).
Watabe-Uchida, M., Zhu, L., Ogawa, S. K., Vamanrao, A. & Uchida, N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74, 858–873 (2012).
Menegas, W. et al. Dopamine neurons projecting to the posterior striatum form an anatomically distinct subclass. Elife 4, e10032 (2015).
Menegas, W., Babayan, B. M., Uchida, N. & Watabe-Uchida, M. Opposite initialization to novel cues in dopamine signaling in ventral and posterior striatum in mice. Elife 6, e21886 (2017).
Menegas, W., Akiti, K., Amo, R., Uchida, N. & Watabe-Uchida, M. Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli. Nat. Neurosci. 21, 1421–1430 (2018).
Engelhard, B. et al. Specialized coding of sensory, motor and cognitive variables in VTA dopamine neurons. Nature 570, 509–513 (2019).
Roeper, J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci. 36, 336–342 (2013).
Steinkellner, T. et al. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons. J. Clin. Invest. 128, 774–788 (2018).
Pereira Luppi, M. et al. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins. Cell Rep. 37, 109975 (2021).
Tolve, M. et al. The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons. Cell Rep. 36, 109697 (2021).
Phillips, R. A. et al. An atlas of transcriptionally defined cell populations in the rat ventral tegmental area. Cell Rep. 39, 110616 (2022).
Aguila, J. et al. Spatial RNA sequencing identifies robust markers of vulnerable and resistant human midbrain dopamine neurons and their expression in Parkinson’s disease. Front. Mol. Neurosci. 14, 699562 (2021).
Monzón-Sandoval, J. et al. Human-specific transcriptome of ventral and dorsal midbrain dopamine neurons. Ann. Neurol. 87, 853–868 (2020).
Cantuti-Castelvetri, I. et al. Effects of gender on nigral gene expression and Parkinson disease. Neurobiol. Dis. 26, 606–614 (2007).
Zheng, B. et al. PGC-1α, a potential therapeutic target for early intervention in Parkinson’s disease. Sci. Transl. Med. 2, 52ra73 (2010).
Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease. Nat. Neurosci. 25, 588–595 (2022).
Smajic, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145, 964–978 (2022).
留言 (0)